Ensysce Biosciences (ENSC) Assets (2017 - 2025)

Ensysce Biosciences (ENSC) has reported Assets for 9 consecutive years, with $7.5 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Assets rose 33.15% year-over-year to $7.5 million in Q4 2025; TTM through Dec 2025 was $7.5 million, a 33.15% increase from a year earlier, with the FY2025 full-year figure at $7.5 million, up 33.15% from the prior year.
• Assets was $7.5 million for Q4 2025 at Ensysce Biosciences, up from $3.2 million in the prior quarter.
• Over five years, Assets peaked at $16.4 million in Q4 2021 and troughed at $1.1 million in Q2 2021.
• A 5-year average of $6.3 million and a median of $5.6 million in 2024 frame the typical range for Assets.
• The widest YoY moves for Assets: up 4566.58% in 2021, down 92.03% in 2021.
• Over 5 years, Assets stood at $16.4 million in 2021, then sank by 64.15% to $5.9 million in 2022, then slumped by 53.98% to $2.7 million in 2023, then surged by 106.69% to $5.6 million in 2024, then soared by 33.15% to $7.5 million in 2025.
• The last three Assets figures came in at $7.5 million (Q4 2025), $3.2 million (Q3 2025), and $5.6 million (Q2 2025), per Business Quant data.